Mateos, M. V., Weisel, K., Terpos, E., Delimpasi, S., Kastritis, E., Zamagni, E., Delforge, M., Ocio, E., Katodritou, E., Gay, F., Larocca, A., Leleu, X., Otero, P. R., Schjesvold, F., Cavo, M. and Dimopoulos, M. A. (2024) “Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma”, Haematologica. Pavia, Italy, 109(7), pp. 2337-2340. doi: 10.3324/haematol.2023.284694.